Development and validation of a prehospital prediction model for acute traumatic coagulopathy by Ithan D. Peltan et al.
RESEARCH Open Access
Development and validation of a
prehospital prediction model for acute
traumatic coagulopathy
Ithan D. Peltan1,2,3*, Ali Rowhani-Rahbar4, Lisa K. Vande Vusse1, Ellen Caldwell1, Thomas D. Rea5,
Ronald V. Maier6 and Timothy R. Watkins1
Abstract
Background: Acute traumatic coagulopathy (ATC) is a syndrome of early, endogenous clotting dysfunction that
afflicts up to 30% of severely injured patients, signaling an increased likelihood of all-cause and hemorrhage-associated
mortality. To aid identification of patients within the likely therapeutic window for ATC and facilitate study of its
mechanisms and targeted treatment, we developed and validated a prehospital ATC prediction model.
Methods: Construction of a parsimonious multivariable logistic regression model predicting ATC — defined as an
admission international normalized ratio >1.5 — employed data from 1963 severely injured patients admitted to an
Oregon trauma system hospital between 2008 and 2012 who received prehospital care but did not have isolated head
injury. The prediction model was validated using data from 285 severely injured patients admitted to a level 1 trauma
center in Seattle, WA, USA between 2009 and 2013.
Results: The final Prediction of Acute Coagulopathy of Trauma (PACT) score incorporated age, injury mechanism,
prehospital shock index and Glasgow Coma Score values, and prehospital cardiopulmonary resuscitation and
endotracheal intubation. In the validation cohort, the PACT score demonstrated better discrimination (area under the
receiver operating characteristic curve 0.80 vs. 0.70, p = 0.032) and likely improved calibration compared to a previously
published prehospital ATC prediction score. Designating PACT scores ≥196 as positive resulted in sensitivity and
specificity for ATC of 73% and 74%, respectively.
Conclusions: Our prediction model uses routinely available and objective prehospital data to identify patients at increased
risk of ATC. The PACT score could facilitate subject selection for studies of targeted treatment of ATC.
Keywords: Acute traumatic coagulopathy, Trauma, Massive transfusion, Prediction model, Prediction score, Prehospital,
Post-traumatic coagulopathy, Risk stratification
Background
Over the last 15 years, randomized trials have often
failed to validate previously promising therapies for
critically ill patients [1–4]. The study of traumatic injury,
which was the cause over 130,000 deaths in the USA in
2013 and remains the leading killer of adults and
children ages 1–44 years [5], is no exception. Uncontrolled
hemorrhage and post-traumatic coagulopathy contribute to
half of injury-related deaths [6], but interventions including
recombinant factor VIIa [7–9] and balanced transfusion
[10] have demonstrated no benefit in broad populations of
injured patients. At least some such negative trials seem
to occur because researchers, who are lacking tools to
quickly identify the subset of patients with disease biology
amenable to targeted therapy, are forced to include
heterogeneous subject populations [11, 12].
The study of acute traumatic coagulopathy (ATC)
poses particular challenges. Present in up to 30% of
severely injured patients on emergency department (ED)
arrival, ATC is an endogenous biologic syndrome
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contributing to, but distinct from, traumatic hemorrhage
in general [13–16]. When defined as an international
normalized ratio (INR) >1.5 on hospital admission, ATC
is associated with a significantly increased risk-adjusted
probability of not only all-cause and hemorrhage-
associated mortality but also multiple organ failure and
venous thromboembolism [13, 14, 17]. As most
bleeding-related deaths occur early after injury, treat-
ment to prevent or mitigate ATC also needs to begin
quickly, potentially even in the prehospital setting.
Diagnosis of ATC in this time frame, however, remains
difficult: the conventional coagulation tests consistently
linked to risk-adjusted outcomes are slow to return, but
issues of validity, reliability, availability, and interpret-
ation hinder broad implementation of otherwise promis-
ing point-of-care testing and viscoelastic measures
[15, 18–21]. A simple, validated, predictive index using
data available prior to ED admission to identify patients at
high risk of ATC — as opposed to major hemorrhage
more generally — could advance research and patient care
by facilitating trial enrollment, efficient specimen collec-
tion, and, ultimately, targeted ATC treatment.
The only prehospital ATC prediction tool reported so
far, the Coagulopathy of Severe Trauma (COAST) score,
is based on vehicle entrapment, chest decompression by
paramedics, and prehospital assessment of blood pres-
sure, temperature, and abdominal/pelvic content injury
[22]. As the score was not externally validated after
development in a single-center Australian cohort, its
generalizability is uncertain [23]. Marked differences in
ambulance crew practice patterns in the USA also pose
obstacles to the application of the COAST score in
trauma settings within the USA.
In the current study, we developed and internally
validated a prediction model for ATC using patient
demographic information, injury characteristics, and
clinical data available to providers before patients’ arrival
in the ED. We then externally validated our score in an
independent trauma cohort and compared its perform-
ance to that of the COAST score.
Methods
Derivation cohort
To derive a multivariable model predicting ATC, we
studied severely injured non-pregnant patients ages
18–89 years, who were entered in the Oregon Trauma
Registry from 2008 to 2012 [24]. Trained staff at the 44
certified trauma centers in Oregon enter details of
injured patients treated at their facility into the registry
if they meet any of the following criteria: intensive care
unit (ICU) admission ≤24 hours from ED arrival; trauma
team activation; prehospital trauma triage criteria met;
surgical intervention; or injury severity score (ISS) >8
[25]. The registry excludes patients who die before ED
arrival or who have isolated hip fracture after a ground-
level fall.
For model derivation, we used data from registry
patients who met one or more of the following criteria
for severe injury: death prior to discharge; admission
directly from the initial trauma center ED to the ICU or
operating room; or transfer from the initial ED to
another state-certified trauma center ED followed by ad-
mission directly to the receiving facility ICU or operat-
ing room. Exclusion criteria included missing admission
INR; initial care outside the trauma system; preadmis-
sion anticoagulant medication; blood transfusion during
prehospital care; and no prehospital care. We also
excluded patients with isolated burn or traumatic brain
injury (no abbreviated injury score (AIS) ≥3 except for
the head) because coagulopathy in these conditions differs
from polytrauma-associated ATC [26]. The Oregon Health
Authority and University of Washington Institutional
Review Boards approved the use of Oregon Trauma
Registry data.
Validation cohort
We validated our model in a prospective cohort (Age of
Transfused Blood and Lung Injury After Trauma Study)
collected at Harborview Medical Center, a level 1 trauma
center in Seattle, WA, USA [27]. Patients with blunt
trauma, age ≥18 years, admitted to the ICU from the ED
(directly or via the operating room) between March
2010 and December 2013 were eligible for enrollment if
transfused ≥1 units of red blood cells within 24 hours of
injury. Study exclusion criteria were acute respiratory
distress syndrome on admission, isolated traumatic brain
injury (radiologic brain injury without non-brain injury),
transfusion ≤6 months prior to admission, pregnancy,
being in police custody, and expected survival <24 hours.
The validation cohort excluded subjects on warfarin,
with no prehospital care, or missing initial INR values.
Trained research staff unaware of coagulopathy status
collected data on patient characteristics, prehospital and
ED care, and outcomes. The University of Washington
Institutional Review Board approved the original study
and granted exempt status to the current secondary
analysis.
Predictor and outcome definitions
ATC was defined as an INR >1.5 on initial measurement
in the first ED [17]. Potential ATC predictors identified
a priori included patient and injury characteristics, and
clinical and management data available before hospital
arrival. Consistent with prior reports [28], we observed
≤1 point difference between prehospital and ED GCS in
85% of subjects not intubated in the field. We therefore
substituted initial ED values for missing prehospital GCS
in subjects not intubated prehospital. GCS was analyzed
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as the difference between the measured GCS and a nor-
mal GCS (15) to provide a positive regression coefficient.
Shock index — the ratio of the first prehospital heart
rate to first prehospital systolic blood pressure (SBP) —
was considered elevated if ≥1 [29]. Prehospital treat-
ments included cardiopulmonary resuscitation, chest de-
compression (needle or tube thoracostomy), and
endotracheal intubation or invasive airway. In addition
to ISS and AIS [30], injury severity indicators included
rollover motor vehicle crash, ejection or need for extri-
cation from vehicle (“entrapment”), and death of another
person on scene [31].
COAST scores were calculated as previously described
(Table 1) [22]. As prehospital providers in the USA do
not systematically evaluate abdominal/pelvic content in-
jury [32], we applied a secondary definition — abdom-
inal/pelvic AIS ≥1 — used in the original description of
the COAST score. Similarly, we employed the first ED
temperature in place of the prehospital value [33].
Missing data
To minimize bias due to missing data, we performed
multiple imputation based on chained equations to
create 50 imputed datasets for both cohorts [34–36].
Missing values were imputed using predictive mean
matching from three nearest neighbors for continuous
variables [37] and logistic regression for binary variables.
Imputation model variables (Additional file 1: Table S1)
included missing and non-missing candidate predictors,
hospital and coagulopathy outcomes, and other corre-
lates of missing variables [38].
Model development
We constructed a multivariable ATC prediction model
from prehospital variables in three steps: candidate
predictor modeling, selection of a parsimonious final
predictor set, and coefficient estimation. To minimize
predictive bias and optimism, we ensured a >10:1 ratio
of outcome events to predictors entered in the model
selection algorithm [36, 39, 40]. To achieve this ratio, we
(1) discarded variables with p values >0.2 in bivariable
analyses or missingness >25%; (2) “forced” a variable based
on the SBP into the final prediction model given its strong
epidemiologic association with ATC and evidence for a
causal mechanism underlying this association; and (3) cre-
ated merged or collapsed candidate predictors (non-ve-
hicular injury mechanism, shock index) when feasible and
supported by bivariable analysis [23, 29, 36]. Continuous
candidate predictors were evaluated without transform-
ation as locally weighted scatterplot smoothing (LOW-
ESS) plots revealed no major non-linearity in predictor/
INR relationships.
We adapted the “majority rules” approach to model
selection described by Vergouwe et al. [41]. Within each
imputed dataset, we evaluated all possible combinations
of predictor variables using a best-subsets approach and
a leaps-and-bounds algorithm adapted for logistic
regression [42–44], choosing the model with the lowest
Akaike information criterion. This likelihood-based
measure of model fit penalizes larger models to reduce
overfitting [45]. The final prediction model included
predictors selected in 50% or more of the imputation-
derived models (Additional file 2: Figure S1). Coeffi-
cients for the final prediction model were obtained by
combining regression coefficients from the 50 imputed
datasets using Rubin’s rules [46]. We created the Predic-
tion of Acute Coagulopathy of Trauma (PACT) score by
rounding raw model coefficients to one decimal place
and multiplying by 100.
Evaluation of model performance
We estimated model optimism in the multiply-imputed
derivation cohort using bootstrap techniques [47]. After
sampling with replacement for 1000 iterations, we
performed the previously described model selection pro-
cedure on each bootstrap sample and compared model
discrimination in the bootstrapped vs. original derivation
cohort. The average difference for the 1000 bootstrapped
samples is an estimate of the deterioration in model
discrimination attributable to sampling bias. To formally
test generalizability, we evaluated the discrimination and
calibration of the PACT and COAST scores when
applied to the validation cohort.
Statistical analysis
For bivariable analyses we employed the unpaired t test
with unequal variance or the Mann-Whitney test for
continuous variables and the chi-square or Fisher’s exact
test for categorical variables. Regression coefficients are
reported with robust standard errors. Model discrimin-
ation measured using the area under the receiver operat-
ing characteristic curve (AUROC) is reported with 95%
confidence intervals and compared using the method of
Delong et al. [48]. Model calibration was evaluated (1)
graphically by plotting the observed versus predicted
Table 1 Coagulopathy of Severe Trauma (COAST) score
Variable Value Score
Entrapment Yes 1
Systolic blood pressure <100 mmHg 1
<90 mmHg 2
Temperature <35 °C 1
<32 °C 2
Chest decompression Yes 1
Abdominal or pelvic content injury Yes 1
Highest total possible 7
Reprinted from Mitra et al. with permission from Elsevier Ltd [22]
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ATC probability across equal quantiles of predicted ATC
risk and (2) using the Hosmer-Lemeshow goodness-of-
fit statistic [49]. A p value >0.1 for this statistic indicates
no significant divergence of observed from predicted
probabilities. As the 7-point COAST score cannot be di-
vided into >7 quantiles, the primary PACT score calibra-
tion analysis also used 7 quantiles of predicted risk. For
other tests, a p value ≤0.05 was considered significant.
We used Stata version 14.0 (StataCorp LP, College
Station, TX, USA) for all analyses and adhered to pub-
lished guidelines for reporting of prediction models [50].
We performed two sensitivity analyses. We tested
whether an alternate ATC definition adding partial
thromboplastin time (PTT) >60 seconds to INR >1.5
altered our results. We also reevaluated the calibration
of our model using deciles of ATC risk predicted by the
PACT score.
Results
The model derivation cohort included 1963 patients en-
rolled in the Oregon Trauma Registry between 2008 and
2012 (Additional file 3: Figure S2). ATC was present in
115 patients (5.9%). Coagulopathic patients were more
severely injured, less likely to be injured while operating
or riding in a motor vehicle, motorcycle or bicycle, more
Table 2 Demographic, injury and clinical characteristics of subjects included in the derivation cohort by coagulopathy status
INR ≤1.5 (n = 1848) INR >1.5 (n = 115) P
Age 44.4 (18.3) 47.4 (20.9) 0.13
Male sex 1338 (72.5) 84 (73.0) 0.90
Race 0.21
Black 58 (3.2) 4 (3.5)
White 1491 (82.2) 86 (76.1)
Other 264 (14.6) 23 (20.4)
Hispanic 185 (10.2) 14 (12.4) 0.50
Minutes from injury to ED arrival 51 (39–70) 49 (34 − 67) 0.14
Mechanism of injury 0.005
Motor vehicle crash 611 (33.1) 31 (27.0)
Motorcycle crash 180 (9.7) 5 (4.3)
Bicycle crash 82 (4.4) 1 (0.9)
Pedestrian struck 106 (5.7) 14 (12.2)
Fall 404 (21.9) 31 (27.0)
Other 465 (25.2) 33 (28.7)
Injury severity indicators
Ejection from vehicle 65 (3.5) 4 (3.5) 1.0
Extrication 129 (7.0) 9 (7.8) 0.73
Rollover motor vehicle crash 150 (8.1) 9 (7.8) 0.91
First measured pre-hospital vital signs
Systolic blood pressure (mmHg) 131 (27) 119 (29) <0.001
Heart rate 94 (22) 94 (30) 0.87
Respiratory rate 20 (5.2) 21 (6.8) 0.33
First recorded non-intubated GCS 15 (13–15) 14 (9 − 15) <0.001
Pre-hospital interventions
Cardiopulmonary resuscitation 25 (1.4) 16 (13.9) <0.001
Chest decompression 24 (1.3) 5 (4.4) 0.024
Intubation 273 (14.8) 44 (38.3) <0.001
Initial ED temperature (°C) 36.4 (0.97) 35.5 (2.12) <0.001
Injury severity score 16.8 (11.7) 25.7 (1.3) <0.001
Death before discharge 122 (6.6) 53 (46.1) <0.001
Hospital length of stay (days) 6 (2–12) 6 (1 − 19) 0.38
Values reported as median (SD), number (%) or median (IQR). ED emergency department, GCS Glasgow Coma Score, INR international normalized ratio
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likely to undergo prehospital interventions and had
lower prehospital SBP and GCS (Table 2).
Compared to the derivation cohort, the 285 subjects
included in the validation cohort (Additional file 3:
Figure S3) had a slightly higher ATC incidence (9.1%),
were more severely injured, and displayed greater
physiologic derangements (Table 3). In-hospital mortality
was 46% in subjects with ATC compared to 7% in subjects
without ATC (p < 0.001) in the derivation cohort and 24%
vs. 7% (p = 0.001) in the validation cohort.
The final ATC prediction model included age, prehospi-
tal cardiopulmonary resuscitation (CPR) and intubation,
prehospital GCS and shock index, and non-vehicular in-
jury mechanism (Table 4). Within the derivation cohort,
the AUROC of the model was 0.74 (95% CI 0.69–0.79).
After conversion to a score (Table 4), the AUROC was
unchanged (0.74, 95% CI 0.69–0.79). Internal validation
using bootstrap methods estimated that predictive opti-
mism contributed 0.02 (95% CI -0.03–0.08) to the mea-
sured AUROC, resulting in an optimism-adjusted
AUROC of 0.72 (95% CI 0.66–0.78). The Hosmer-
Lemeshow goodness-of-fit test demonstrated no evidence
for inadequate model fit (χdf=5, 2.82, p = 0.73). An inter-
active PACT score calculator is available online at
www.pactscore.com [51].
Application of the PACT score to the independent val-
idation cohort yielded an AUROC of 0.80 (95% CI 0.72–
0.88). The PACT score AUROC was significantly greater
than the COAST score AUROC (0.70, 95% CI 0.60–0.80,
p = 0.032 for comparison; Fig. 1). Including PTT >60 sec-
onds in the definition of ATC yielded similar results
(AUROC 0.80 vs. 0.71, p = 0.038). There was no statis-
tical evidence of inadequate calibration for either the
PACT score (Hosmer-Lemeshow goodness-of-fit statistic
χdf=7 = 4.02, p = 0.77), or the COAST score (χdf=7 = 11.25,
p = 0.13). However, graphical evaluation suggested good
calibration of the PACT score but an inconsistent rela-
tionship between observed and predicted ATC risk at
higher COAST score values (Fig. 2). Dividing the PACT
score into deciles rather than seven quantiles of pre-
dicted risk did not alter these conclusions (χdf=10 = 8.30,
p = 0.59).
Setting the PACT score cutoff at ≥196 maximized sen-
sitivity and specificity at 73.1% and 73.8%, respectively
(Table 5). Applying this threshold to the validation
cohort, 191 of 198 patients (96.5%) with a PACT score
<196 were correctly identified as not having coagulopa-
thy. Among those with a positive PACT score, 19 of 87
(21.8%) had coagulopathy. At the COAST score recom-
mended threshold of ≥3, sensitivity was 26.9% and speci-
ficity was 86.1%. Of 43 COAST scores ≥3, 36 (84.7%)
were false positives (Table 5).
Discussion
We developed and externally validated a model predict-
ing ATC prior to ED arrival in patients with severe
trauma. The PACT score, incorporating a small number
of objective and readily measured data elements rou-
tinely available to prehospital providers, exhibited good
discrimination and calibration when tested in an inde-
pendent trauma cohort and performed better in both
domains than the only previously published prehospital
ATC prediction tool.
Benefits of prehospital identification, expedited triage,
and receiving hospital notification are well-recognized
for conditions where time to treatment affects outcomes
[31, 52, 53]. Given the time course of exsanguination-
related mortality and the early separation of survival
curves for patients with and without ATC, the best time
to intervene in ATC appears to be within minutes of
Table 3 Demographic, injury, and resuscitation characteristics of





Age 44.6 (18.5) 48.2 (19.0)
Male sex 1422 (72.6) 204 (71.6)
Non-white race 349 (18.1) 40 (14.0)
Hispanic 199 (10.3) 18 (6.4)
Minutes from injury to ED arrival 51 (38–70) 56 (40–86)
Blunt injury 1727 (88.0) 285 (100)
Mechanism of injury
Motor vehicle crash 642 (32.7) 104 (36.5)
Motorcycle crash 185 (9.4) 50 (17.6)
Bicycle crash 83 (4.2) 10 (3.5)
Pedestrian struck 120 (6.1) 51 (17.9)
Fall 435 (22.2) 44 (15.4)
Other 498 (25.4) 26 (9.1)
First recorded prehospital vital signs
Systolic blood pressure (mmHg) 131 (28) 116 (37)
Heart rate 94 (23) 99 (26)
Respiratory rate 20 (5.3) 19 (7.6)
First recorded non-intubated GCS 15 (13–15) 14 (8–15)
Pre-hospital interventions
Cardiopulmonary resuscitation 41 (2.1) 9 (3.2)
Chest decompression 29 (1.5) 8 (2.8)
Intubation 317 (16.2) 145 (50.9)
Initial ED temperature 36.3 (1.07) 35.9 (1.23)
Injury severity score 17.3 (12.0) 32.3 (15.1)
Admission INR 1.19 (0.74) 1.25 (0.26)
Acute traumatic coagulopathy 115 (5.9) 26 (9.1)
Death before discharge 175 (8.9) 37 (13.0)
Values reported as median (SD), number (%) or median (IQR). ED emergency
department, GCS Glasgow Coma Score, INR international normalized ratio
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injury [14, 54]. We created the PACT score in response
to calls for improved ATC recognition within this win-
dow of opportunity [55, 56]. The implementation of the
score in clinical care must await clinical trials of
PACT score-guided therapy. In the meantime, stratifica-
tion of trauma patients according to ATC risk using the
PACT score could aid study of this condition’s mecha-
nisms and facilitate interventional trials of its treatment.
Enrolling patients at high risk of ATC would foster effi-
cient resource use, reduce heterogeneity, and enrich co-
horts with the subjects most likely to benefit from a
particular treatment, thereby increasing study power.
The PACT score demonstrated good ability to discrim-
inate patients with ATC. Discrimination improved in the
validation cohort compared to the derivation cohort,
suggesting the score has better accuracy in patients who
are sicker and/or suffered blunt injury. The PACT score
cannot, however, diagnose ATC with perfect accuracy
and would benefit from testing against physician judg-
ment. Clinical application therefore largely awaits studies
investigating targeted prehospital or “ED doorway” ther-
apies. The appropriate PACT score cutoff will, moreover,
depend on the specific application. In a low-prevalence
environment, a PACT score ≥160 (92% sensitivity, 59%
specificity) could guide treatment selection for low-risk
interventions. Alternatively, for a theoretical study
recruiting high-risk patients from the validation cohort,
a PACT score ≥250 would enroll 38 patients of whom
29% would have ATC. This compares favorably with the
COAST score at its recommended threshold (27 sub-
jects, 19% ATC) or unselected enrollment (285 subjects,
9% ATC).
Viscoelastic assays deliver partial results within 10–15
minutes of test initiation, allowing attractively rapid
post-admission coagulopathy evaluation at the minority
of level 1 trauma centers where these assays are available
[57, 58]. However, startup costs, assay system inter-
changeability and reliability issues, and particularly the
absence of a consensus outcome-linked viscoelastic ATC
definition pose barriers to the application of viscoelastic
assays in clinical care and research outside high-volume,
high-resource trauma centers [20, 57, 59, 60]. Because
the PACT score accelerates ATC risk stratification
relative to viscoelastic assays and is applicable in the
settings without access to these tests where most
trauma patients receive their initial care, we believe
the PACT score has a role in ATC research and,
eventually, in clinical care.













First prehospital shock index ≥1 Forced into model Yes 0.933 0.249 0.324 Yes/no 90
Age 100 % Yes 0.0119 0.006 0.275 Age, rounded to
nearest decade
1
Mechanism of injury not motor
vehicle, motorcycle, or bicycle crash
100 % Yes 0.514 0.215 0.256 Yes/no 50
Number of GCS points below 15 98 % Yes 0.0705 0.032 0.171 15 – GCS 7
Prehospital CPR 100 % Yes 1.198 0.461 0.188 Yes/no 120
Prehospital intubation or advanced
airway
74 % Yes 0.510 0.315 0.219 Yes/no 50
Prehospital chest decompression 0 % No — — — — —
Time from injury to emergency
department
6 % No — — — — —
Constant N/A Yes -4.256 0.334 — — —
aStandardized regression coefficients represent the change in the log-odds of acute traumatic coagulopathy for a 1 standard deviation increase in the value of the
predictor. CPR cardiopulmonary resuscitation, GCS Glasgow Coma Score, N/A not applicable
Fig. 1 Discrimination of prehospital acute traumatic coagulopathy
prediction scores. Prediction of Acute Coagulopathy of Trauma (PACT)
score area under the receiver operating characteristic curve 0.80 (95 %
CI 0.72–0.88) in the validation cohort vs. 0.68 (95 % CI 0.60–0.80) for the
Coagulopathy of Severe Trauma (COAST) score (p = 0.038)
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Consistent with previous studies, patients with ATC
had substantially increased mortality. Higher ATC mor-
tality in the less severely injured derivation cohort may
reflect differences in timing of cohort entry or outcome
variation between a multilevel trauma system and a sin-
gle high-volume level 1 trauma center [61]. Overall, vari-
ables in our model indicate greater injury relative to
physiologic reserve, in line with prior research correlat-
ing ATC prevalence with injury severity and hypoperfu-
sion [13, 62]. Besides suggesting particularly severe
injury, the predictive utility of prehospital CPR may also
signal a contribution from the type of coagulopathy
previously observed in survivors of non-traumatic
cardiac arrest [63]. However, this study was not designed
to identify ATC risk factors and our results should not
be interpreted as evidence of causal associations between
the studied predictors and ATC.
Our study strengths include an independent cohort for
external model validation, sufficient events per variable
tested, and a model selection algorithm balancing the
predictive utility of the variables against the risk of over-
fitting. Whereas complete case analysis would have lim-
ited our effective sample size and introduced bias into
model development and evaluation [36, 64], our ap-
proach using multiple imputation to manage missing
data avoided excluding patients with missing predictor
values and has been widely recommended in recent litera-
ture on predictive models [36, 50, 64]. We nevertheless
cannot exclude residual bias due to missing predictor or
outcome data.
The COAST score calculation required several approx-
imations due to differences between its derivation dataset
and our datasets. We estimated prehospital temperature
using a validated extrapolation and applied the original
Fig. 2 Calibration of prehospital acute traumatic coagulopathy prediction scores in the validation cohort. Observed acute traumatic coagulopathy
(ATC) probability vs. risk predicted by the Prediction of Acute Coagulopathy of Trauma (PACT) score (a) and Coagulopathy of Severe Trauma (COAST)
score (b). Circles, proportional to subjects represented, indicate actual score (COAST) or 1/7th quantiles of predicted risk (PACT). Error bars represent
95 % confidence intervals for observed ATC probabilities
Table 5 Operating characteristics of the Prediction of Acute
Coagulopathy of Trauma (PACT) score in the validation cohort
PACT score ≥100 ≥150 ≥200 ≥250 ≥300
Patients
True positive 25 25 18 11 3
False positive 186 125 67 27 9
True negative 73 134 192 232 250
False negative 1 1 8 15 23
Operating characteristics
Sensitivity (%) 96.2 96.2 69.2 42.3 11.5
Specificity (%) 28.2 51.7 74.1 89.6 96.5
Positive likelihood ratio 1.34 1.99 2.68 4.06 3.32
Negative likelihood ratio 0.14 0.07 0.42 0.64 0.92
COAST score ≥1 ≥2 ≥3 ≥4 ≥5
Patients
True positive 23 15 7 1 0
False positive 177 89 36 2 0
True negative 82 170 223 257 259
False negative 3 11 19 25 26
Operating characteristics
Sensitivity (%) 88.5 57.7 26.9 3.9 0
Specificity (%) 31.7 65.6 86.1 99.3 100
Positive likelihood ratio 1.29 1.68 1.94 4.98 —
Negative likelihood ratio 0.36 0.64 0.85 0.97 1
PACT score Prediction of Acute Coagulopathy of Trauma score, COAST score
Coagulopathy of Severe Trauma score
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manuscript surrogate for prehospital providers’ subjective
abdominal/pelvic injury evaluation [22, 33]. These
modifications may have penalized the COAST score in
comparisons with the PACT score.
In parallel to past studies [22], we focused on severely
injured patients in order to create a tool for stratifying
among patients at risk of ATC rather than for screening
unselected trauma patients for ATC. Selection of severely
injured patients for both cohorts, however, relied on retro-
spective application of severity markers and other data
available only after hospital admission. Though parallel in
this respect to the procedures applied for development
and validation of the COAST score [22] and a well-known
prediction model for massive transfusion [65, 66], cohort
selection for prehospital prediction model building and
testing would ideally use prehospital data. The PACT
score may perform differently if applied to patients identi-
fied as severely injured solely from information available
prehospital or upon ED arrival.
Our study has several additional limitations. We
defined ATC as an INR >1.5 on hospital admission, a
validated definition [17] which may nevertheless not
capture all mechanisms — including hyperfibrinolysis —
relevant to the impact of the syndrome on trauma out-
comes. Substituting the ATC definition employed by
Mitra et al. (INR >1.5 or PTT >60 seconds) did not alter
our results. As we were unable to exclude subjects with
liver disease, the derangement of INR in some subjects
may have resulted from preexisting conditions.
The model derivation cohort was less severely injured
and, as a result, had less physiologic derangement and
lower mortality than the validation cohort. Compared to
model evaluation in an identically defined cohort, the
two cohorts’ entry criteria and mortality actually pro-
vided a more rigorous generalizability test. Global varia-
tions in injury patterns and prehospital care could
decrease the accuracy of our prediction model outside of
North America. Finally, the lower-than-expected ATC
incidence in the validation cohort yielded a suboptimal
sample size for model validation [67]. Though it repre-
sents one of the few validated prediction tools, repeating
the PACT score validation in a larger, more diverse
trauma cohort identified from prehospital criteria would
be useful to further confirm its generalizability.
Conclusions
In conclusion, we report derivation and external
validation of a prediction model that employs object-
ive, routinely collected prehospital data to identify
patients at increased risk of ATC. The PACT score
exhibited improved discrimination and calibration
relative to a previously reported ATC prediction
model. Application of the PACT score during study
recruitment could aid therapeutic trials by enriching
enrolled cohorts with the patients most likely to
benefit from treatments targeting coagulopathy.
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